Cat.No：GM-81148AB
Product：Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
Cat.No：GM-81148AB
Product：Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
GM-81148AB-100 100μg
GM-81148AB-1mg 1mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Drug-to-Antibody Ratio (DAR) 4.0
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target Tissue Factor (TF)
Clone Tisotumab vedotin
Alternative Names TF-011-MMAE; HuMax-TF-ADC
Antibody Type/ Isotype Monoclonal Human IgG1(REEM),Kappa
Description Tisotumab vedotin is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. It is administered by infusion into a vein.
Formulation 20 mM Histidine, pH 6.0
Storage temp. Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.
Cat.No：GM-81148AB
Product：Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
GM-81148AB-100 100μg
GM-81148AB-1mg 1mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Drug-to-Antibody Ratio (DAR) 4.0
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target Tissue Factor (TF)
Clone Tisotumab vedotin
Alternative Names TF-011-MMAE; HuMax-TF-ADC
Antibody Type/ Isotype Monoclonal Human IgG1(REEM),Kappa
Description Tisotumab vedotin is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. It is administered by infusion into a vein.
Formulation 20 mM Histidine, pH 6.0
Storage temp. Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.
